Symbolbild · KI-generiert
Vanta Holdings Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Vanta Holdings Inc. is a consumer health sciences and longevity company advancing a U.S.-focused peptide therapy, functional nutraceutical, and premium hydration ecosystem centered on preventative wellness and healthspan extension, positioning the Company to participate in the expanding longevity economy. Through its U.S.-focused telehealth-enabled peptide therapy platform, supported by commercialization infrastructure and FDA-registered compounding pharmacy relationships, Vanta is pursuing opportunities across recovery, metabolic wellness, performance optimization, and healthy aging categories. Complementing this initiative, the Company develops, manufactures, and distributes longevity-focused nutraceutical and premium hydration products through its Vanta brand and select private-label partnerships, including its flagship Blackwater and BlackPowder product portfolio. Based in British Columbia, Canada, Vanta owns exclusive rights to a natural alkaline spring water aquifer and operates a 40,000-square-foot, Health Canada- and HACCP-certified manufacturing facility.
Company description as published by the issuer via Canadian Securities Exchange.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Vanta Holdings Inc. | VNTA | CSE | 4 Mio. USD |
| PharmaTher Holdings Ltd. | PHRM | CSE | 4 Mio. USD |
| Restart Life Sciences Corp. | HEAL | CSE | 4 Mio. USD |
| Promino Nutritional Sciences Inc. | MUSL | CSE | 4 Mio. USD |
| XORTX Therapeutics Inc. | XRTX | TSXV | 4 Mio. USD |
| Kane Biotech Inc. | KNE | TSXV | 4 Mio. USD |
| PanGenomic Health Inc. | NARA | CSE | 4 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.